Remarkably, the three COVID-19 patients that exhibited moderate to high perivascular ACE2 expression in the brain all presented with neurological symptoms, while all ACE2-negative patients remained free from such manifestations (Figure 1D). Here, ACE2 is linked to COVID-19.